[{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.211","meta":{"versionId":"19","lastUpdated":"2023-12-21T17:43:03.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2015-04-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.117.1.7.1.211"}],"version":"20150430","name":"InjectableFactorXaInhibitorForVTEProphylaxis","title":"Injectable Factor Xa Inhibitor for VTE Prophylaxis","status":"retired","experimental":false,"date":"2015-04-30T01:00:08-04:00","publisher":"TJC EH Steward","expansion":{"identifier":"urn:uuid:b6b4ea6c-e8b2-4dd8-8ea9-b1dfeab00ee9","timestamp":"2024-02-11T11:07:01-05:00","total":4,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"861356","display":"0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"861360","display":"0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"861363","display":"0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"861365","display":"0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"}]}}]
